A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures
Authors
Keywords
-
Journal
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume 31, Issue 4, Pages 616-624
Publisher
Wiley
Online
2016-12-18
DOI
10.1111/jdv.14085
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology of Lentigo Maligna and Lentigo Maligna Melanoma in the Netherlands, 1989–2013
- (2016) Karin Greveling et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Twelve-week Treatment of Lentigo Maligna with Imiquimod Results in a High and Sustained Clearance Rate
- (2015) G Kirtschig et al. ACTA DERMATO-VENEREOLOGICA
- Five-year recurrence rate of lentigo maligna after treatment with imiquimod
- (2015) A.C. Kai et al. BRITISH JOURNAL OF DERMATOLOGY
- Combination Topical Therapy for Conjunctival Primary Acquired Melanosis With Atypia and Periocular Lentigo Maligna
- (2015) Emily M. Bratton et al. CORNEA
- A quantitative systematic review of the efficacy of imiquimod monotherapy for lentigo maligna and an analysis of factors that affect tumor clearance
- (2015) Ariana N. Mora et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type
- (2015) Susan M. Swetter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Surveillance for treatment failure of lentigo maligna with dermoscopy andin vivoconfocal microscopy: new descriptors
- (2014) P. Guitera et al. BRITISH JOURNAL OF DERMATOLOGY
- Treatment of Lentigo Maligna with Imiquimod before Staged Excision
- (2014) MURRAY A. COTTER et al. DERMATOLOGIC SURGERY
- In vivo reflectance confocal microscopy to monitor the response of lentigo maligna to imiquimod
- (2014) Ivette Alarcon et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Increased incidence of melanoma in situ in Denmark from 1997 to 2011
- (2014) Anita Toender et al. MELANOMA RESEARCH
- Incidence of lentigo maligna in Olmsted County, Minnesota, 1970 to 2007
- (2013) Sultan A. Mirzoyev et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Improving Management and Patient Care in Lentigo Maligna by Mapping With In Vivo Confocal Microscopy
- (2013) Pascale Guitera et al. JAMA Dermatology
- A Randomized Trial of the Off-label Use of Imiquimod, 5%, Cream With vs Without Tazarotene, 0.1%, Gel for the Treatment of Lentigo Maligna, Followed by Conservative Staged Excisions
- (2012) Mark A. Hyde et al. ARCHIVES OF DERMATOLOGY
- Melanoma In Situ Treated Successfully Using Imiquimod After Nonclearance with Surgery: Review of the Literature
- (2012) Lixia Z. Ellis et al. DERMATOLOGIC SURGERY
- Lentigo maligno tratado com imiquimode tópico: o valor da dermatoscopia no monitoramento clínico
- (2011) Mariana Carvalho Costa et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Failed Treatment of Amelanotic Lentigo Maligna With Imiquimod Followed by Pigment Production
- (2010) Kathryn J. Martires et al. ARCHIVES OF DERMATOLOGY
- Revised U.K. guidelines for the management of cutaneous melanoma 2010
- (2010) J.R. Marsden et al. BRITISH JOURNAL OF DERMATOLOGY
- Treatment of Lentigo Maligna with Imiquimod Cream: A Long-Term Follow-Up Study of 10 Patients
- (2010) TIM VAN MEURS et al. DERMATOLOGIC SURGERY
- Methods for quantifying intrafollicular drug delivery: a critical appraisal
- (2010) Victor M Meidan Expert Opinion on Drug Delivery
- Periocular lentigo maligna treated with imiquimod
- (2010) Jennifer O'Neill et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Topical Imiquimod for Periocular Lentigo Maligna
- (2010) Hakan Demirci et al. OPHTHALMOLOGY
- Remissão de lentigo maligno extenso após tratamento com imiquimod
- (2009) Christiane D. Piazza et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up
- (2009) A.M. Powell et al. BRITISH JOURNAL OF DERMATOLOGY
- The hair follicle barrier to involvement by malignant melanoma
- (2009) Olga Pozdnyakova et al. CANCER
- Drug Targeting Through Pilosebaceous Route
- (2009) Rashmi Chourasia et al. CURRENT DRUG TARGETS
- Long-Term Follow-Up of a Hemifacial Lentigo Maligna Treated Using 5% Imiquimod
- (2009) Anne M. Ramsdell et al. DERMATOLOGIC SURGERY
- Recurrence of Lentigo Maligna and Development of Invasive Melanoma after Treatment of Lentigo Maligna with Imiquimod
- (2009) Courtney S. Woodmansee et al. DERMATOLOGIC SURGERY
- Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline
- (2009) Claus Garbe et al. EUROPEAN JOURNAL OF CANCER
- Assessing Quality of Case Series Studies: Development and Validation of an Instrument by Herbal Medicine CAM Researchers
- (2009) Angela Weihong Yang et al. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
- Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis
- (2009) Kristin Turza et al. JOURNAL OF CUTANEOUS PATHOLOGY
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2009) Alessandro Liberati et al. PLOS MEDICINE
- Topical Imiquimod Therapy for Lentigo Maligna
- (2008) Mary-Helen Mahoney et al. ANNALS OF PLASTIC SURGERY
- Imiquimod Treatment of Lentigo Maligna: An Open-Label Study of 34 Primary Lesions in 32 Patients
- (2008) Urs V. Buettiker et al. ARCHIVES OF DERMATOLOGY
- Imiquimod, a Toll-Like Receptor 7 Agonist, Inhibits Melanogenesis and Proliferation of Human Melanocytes
- (2008) Hee Young Kang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started